FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3174718000> ?p ?o ?g. }

• W3174718000 abstract "Background Unfractionated heparin remains to be the only parenteral anticoagulant for various indications. Currently heparin is mainly derived from porcine mucosal heparin tissues. The USFDA and other regulatory agencies have considered resourcing heparin from alternate sources. Currently sheep (ovine) and cow (bovine) mucosal heparins are being developed for clinical use. The purpose of this study was to compare commercially available porcine heparin with the heparins obtained from bovine and ovine mucosal sources. Materials and Methods Bovine, ovine and porcine heparins were obtained from various commercial sources. Potencies of each heparin were determined by an amidolytic anti-Xa assay in relation to the USP heparin standard. Individual groups of primates (n=4) were administered 100 anti-Xa U/kg dosage of bovine, ovine or porcine heparin via intravenous route. Blood samples were collected at baseline, 15, 30, 60 and 120 minutes post-administration. Anti-Xa and anti-IIa activities were measured to determine circulating heparin concentrations using commercially available USP compliant kits (Aniara Diagnostica, West Chester, OH). These drug concentrations were used to determine pharmacokinetic parameters such as area under the curve (AUC), half-life (t1/2), clearance (Cl) and volume of distribution (Vd) using the PKSolver add-in for Excel. The tissue factor pathway inhibitor (TFPI) levels were measured at 15 minutes. Results The concentration vs. time curves for the three heparins were almost superimposable. Peak drug levels of approximately 1.5 and 1.4 U/mL were measured using anti-Xa and anti-IIa assays, respectively. After 2 hours, circulating drug levels were decreased to approximately 0.4 U/mL for all heparins. Pharmacokinetic parameters calculated from plasma concentration-time curves indicated that all three heparins behaved similarly. Mean half-life based on anti-Xa activity ranged from 44 ± 13 min for ovine heparin to 71 ± 18 min for bovine heparin. Slightly longer half-lives were observed using plasma concentrations determined using anti-IIa activity. Mean AUC values based on anti-Xa or anti-IIa activities were comparable for all heparins. Mean Vd (~60 ml/kg) and Cl (~0.75 ml/kg/min) were also comparable for all heparins. The TFPI levels were similar for the porcine and ovine heparin whereas the bovine heparin exhibited lower levels. Conclusion At a gravimetric level the bovine heparin exhibits a lower anticoagulant potency (140 U/mg) than ovine or porcine heparins (200 U/mg). USP cross-referenced anti-Xa potency adjusted based dosing results in comparable pharmacokinetic profiles for all three heparins. Therefore such dosing may provide uniform levels of anticoagulation for the parenteral indications for heparins. These observations warrant clinical validations in the specific indications. Support or Funding Information None. This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal." @default.
• W3174718000 created "2021-07-05" @default.
• W3174718000 creator A5007859032 @default.
• W3174718000 creator A5030457785 @default.
• W3174718000 creator A5046266128 @default.
• W3174718000 creator A5047210555 @default.
• W3174718000 creator A5047366817 @default.
• W3174718000 creator A5062178005 @default.
• W3174718000 creator A5077293472 @default.
• W3174718000 creator A5091652199 @default.
• W3174718000 date "2019-04-01" @default.
• W3174718000 modified "2023-09-24" @default.
• W3174718000 title "Pharmacokinetic and Pharmacodynamic Profiles of Potency‐Adjusted Doses of Bovine, Ovine and Porcine Heparin are Comparable in a Primates Model" @default.
• W3174718000 doi "https://doi.org/10.1096/fasebj.2019.33.1_supplement.515.3" @default.
• W3174718000 hasPublicationYear "2019" @default.
• W3174718000 type Work @default.
• W3174718000 sameAs 3174718000 @default.
• W3174718000 citedByCount "0" @default.
• W3174718000 crossrefType "journal-article" @default.
• W3174718000 hasAuthorship W3174718000A5007859032 @default.
• W3174718000 hasAuthorship W3174718000A5030457785 @default.
• W3174718000 hasAuthorship W3174718000A5046266128 @default.
• W3174718000 hasAuthorship W3174718000A5047210555 @default.
• W3174718000 hasAuthorship W3174718000A5047366817 @default.
• W3174718000 hasAuthorship W3174718000A5062178005 @default.
• W3174718000 hasAuthorship W3174718000A5077293472 @default.
• W3174718000 hasAuthorship W3174718000A5091652199 @default.
• W3174718000 hasConcept C110121322 @default.
• W3174718000 hasConcept C111113717 @default.
• W3174718000 hasConcept C112705442 @default.
• W3174718000 hasConcept C126322002 @default.
• W3174718000 hasConcept C134306372 @default.
• W3174718000 hasConcept C139254425 @default.
• W3174718000 hasConcept C185592680 @default.
• W3174718000 hasConcept C202751555 @default.
• W3174718000 hasConcept C2777557582 @default.
• W3174718000 hasConcept C2778205648 @default.
• W3174718000 hasConcept C2780035454 @default.
• W3174718000 hasConcept C33923547 @default.
• W3174718000 hasConcept C55493867 @default.
• W3174718000 hasConcept C57992300 @default.
• W3174718000 hasConcept C71924100 @default.
• W3174718000 hasConcept C98274493 @default.
• W3174718000 hasConceptScore W3174718000C110121322 @default.
• W3174718000 hasConceptScore W3174718000C111113717 @default.
• W3174718000 hasConceptScore W3174718000C112705442 @default.
• W3174718000 hasConceptScore W3174718000C126322002 @default.
• W3174718000 hasConceptScore W3174718000C134306372 @default.
• W3174718000 hasConceptScore W3174718000C139254425 @default.
• W3174718000 hasConceptScore W3174718000C185592680 @default.
• W3174718000 hasConceptScore W3174718000C202751555 @default.
• W3174718000 hasConceptScore W3174718000C2777557582 @default.
• W3174718000 hasConceptScore W3174718000C2778205648 @default.
• W3174718000 hasConceptScore W3174718000C2780035454 @default.
• W3174718000 hasConceptScore W3174718000C33923547 @default.
• W3174718000 hasConceptScore W3174718000C55493867 @default.
• W3174718000 hasConceptScore W3174718000C57992300 @default.
• W3174718000 hasConceptScore W3174718000C71924100 @default.
• W3174718000 hasConceptScore W3174718000C98274493 @default.
• W3174718000 hasIssue "S1" @default.
• W3174718000 hasLocation W31747180001 @default.
• W3174718000 hasOpenAccess W3174718000 @default.
• W3174718000 hasPrimaryLocation W31747180001 @default.
• W3174718000 hasRelatedWork W1978032370 @default.
• W3174718000 hasRelatedWork W1979757582 @default.
• W3174718000 hasRelatedWork W2071747460 @default.
• W3174718000 hasRelatedWork W2090099591 @default.
• W3174718000 hasRelatedWork W2227061539 @default.
• W3174718000 hasRelatedWork W2332367370 @default.
• W3174718000 hasRelatedWork W2400461952 @default.
• W3174718000 hasRelatedWork W2811032560 @default.
• W3174718000 hasRelatedWork W1914240745 @default.
• W3174718000 hasRelatedWork W2603979525 @default.
• W3174718000 hasVolume "33" @default.
• W3174718000 isParatext "false" @default.
• W3174718000 isRetracted "false" @default.
• W3174718000 magId "3174718000" @default.
• W3174718000 workType "article" @default.